Study Using CP-461 to Treat Advanced Prostate Cancer

Completed · Phase 2

Conditions studied: Prostate Cancer

In brief

The purpose of this study is to investigate whether an investigational drug, CP-461, is safe and effective for the treatment of patients with prostate cancer and who have measurable disease.

Key facts

Study ID

NCT00036075

Run by

Astellas Pharma Inc

People needed

25

Starts

2001-08-01

Expected to finish

2005-12-01

Last updated by the study team

2011-10-17

Who can join

Age: 18 and older. Sex: male. Healthy volunteers: not accepted.

Where it is running

• Columbia Presbyterian Medical Center — New York, New York, United States
• University of Washington — Seattle, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.